News

Ingredion’s Tate & Lyle takeover bid offers scale and science

US ingredients business Ingredion has made a £2.7bn takeover bid for its London-listed peer Tate & Lyle.

According to the Financial Times, Tate & Lyle’s shares jumped 45% after the company confirmed the board was in discussions about the deal.

The proposed bid, which follows a number of earlier approaches from Ingredion, would result in Tate & Lyle shareholders receiving up to 615 pence per share (595p in cash and up to 20p in dividends). “That equates to a 57% premium to the share price before the bid was disclosed,” reported the FT.

Experts told Ingredients Network that combining these two powerhouses makes sense – in terms of scale, sourcing, reach and, crucially, adapting to evolving consumer and customer demands as food manufacturers look at their suppliers for more than just deliverers of ingredients.

“This deal absolutely makes sense for both companies,” said Bryan Quoc Le, founder and CEO at Mendocino Food Consulting, based in California, US. “Both companies are major powerhouses in the ingredient space and have many potential synergies between their ingredient product lines. [And] both hold tremendous brand visibility and perception of high quality, advanced ingredient offerings within the food industry.”

Ingredion generated $7.22 billion (£5.37bn) in revenue in 2025, while Tate & Lyle expects revenue of around £2.12 billion (£1.58bn). However, the latter admitted to a “disappointing” year when publishing its annual figures last month, May. “The year has been one of significant progress and challenge,” explained chief executive Nick Hampton.

There is therefore a straightforward financial case for this deal. Organic growth across much of the food sector remains modest, with pricing contributing more growth than volume.

For Tate & Lyle, the deal provides access to greater scale at a time when ingredient suppliers are facing “increasing complexity” from both customers and regulators, said Matthew Walls, president at Edible Brands. For Ingredion, the deal broadens capabilities and geographic reach, he added.

Size matters… but so do science and solutions

Acquisitions certainly provide access to capabilities, customers and revenue streams that are difficult to build organically within a reasonable timeframe.

“The combined business would become one of the largest ingredients groups globally,” said Filiberto Amati, partner at FMCG consultancy Amati & Associates. “However, the rationale is less about scale and more about capability,” he added.

The importance of texture has soared in food formulation, aiding trends to cut sugar, fat and dairy. Clean label reformulation is an ever-present requirement.

Quoc Le explained: “With Tate & Lyle's historic dominance of the sweetener and sugar space, and Ingredion possessing the state of the art technologies for gums, starches, and other texture modifiers, their combined intellectual property and manufacturing capabilities are sure to accelerate development in the space.”

Together, they can offer food manufacturers a broader range of solutions at a time when reformulation has become a priority - not least with the growth in use of GLP-1 medications.

GLP-1: Ingredients suppliers crucial as demands change

Consumers using appetite-suppressing treatments typically eat less, look for higher protein and fibre content and reduce sugar consumption. Food manufacturers are responding with product reformulation, creating demand for the kind of ingredients solutions a combination of Tate & Lyle and Ingredion could provide.

Indeed, this deal more than anything reflects how customer requirements are evolving. Food manufacturers increasingly want ingredient suppliers that can solve multiple formulation challenges at once. Reducing sugar, increasing fibre, maintaining texture and meeting clean label requirements are now part of the same conversation. Suppliers that can provide integrated solutions have an advantage.

“Demand for clean label is permeating the consumer landscape [... and] while consumers want healthier food, they don’t want to compromise on taste or mouthfeel,” explained Beth Johnson, associate in the consumer, food and agribusiness teams at US firm Focus Investment Banking. “The shift in consumer preferences is pushing food & beverage makers – and in turn, ingredients manufacturers – to reshape their products and formulations,” she added.

Johnson suggested the proposed Ingredion-Tate & Lyle deal “reinforces how critical ingredients makers are in today’s rapidly changing market, especially companies that specialise in flavour innovations and/or formulations that support healthier products”.

Consolidation shows no sign of slowing down

Charlie Packwood, managing director at talent and search consultancy for speciality ingredients and flavour and fragrances industries Aston Chambers, recently identified Tate & Lyle as one of the likely acquisition targets within the sector, with Ingredion one of the most logical strategic acquirers.

The rationale was clear, he explained on social media: “Tate & Lyle’s strategic pivot towards higher-margin speciality ingredients; increased focus on texture, mouthfeel and sugar reduction solutions; strong global infrastructure and customer relationships; and a highly complementary fit with Ingredion’s existing portfolio and geographic footprint.”

And there have been several notable transactions in recent years that mirrored this, commanding double-digit EBITDA valuations, from the Nexture-Frulact deal to Tate & Lyle’s acquisition of CP Kelco.

The latter, as Hampton explained in the end of year results recently, is already “driving increased levels of customer traction and a stronger new business pipeline”. Ingredion also has a controlling stake in PureCircle, the stevia supplier.

With “strong acquirer interest” in the space, there will likely be a wave of M&A across the ingredients landscape, Johnson at Focus predicted, adding: “This could include large strategics acquiring smaller, privately owned companies as well as private equity pursuing consolidation opportunities.”

Other recent transactions elsewhere in the sector point in the same direction. IFF's sale of its Food Ingredients business to CVC allows IFF to concentrate on taste, scent and health, while the buyer gains scale in ingredients, for example.

Transactions such as Mars acquiring Kellanova, Nestlé reshaping parts of its portfolio and Kraft Heinz reviewing its brand mix all create new demands for ingredient suppliers, as well.

As Walls explained: “Food manufacturers are asking suppliers to do more than simply provide ingredients. They want innovation partners that can help solve formulation, nutrition, cost and supply chain challenges simultaneously.”